# A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in Argentina

> **NCT04955964** · — · COMPLETED · sponsor: **Takeda** · enrollment: 48 (actual)

## Conditions studied

- Angioedemas, Hereditary

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04955964
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2023-08-07
- **Final completion:** 2023-08-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955964, "A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in Argentina". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04955964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*